Lamdong Pharmaceutical JSC (HNX:LDP)
12,500
+100 (0.81%)
At close: Apr 16, 2025
HNX:LDP Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Cash & Equivalents | 11,451 | 16,205 | 16,619 | 65,159 | 28,257 | Upgrade
|
Short-Term Investments | 3,014 | 2,896 | 1,788 | - | - | Upgrade
|
Trading Asset Securities | 2,692 | 1,121 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 17,157 | 20,222 | 18,407 | 65,159 | 28,257 | Upgrade
|
Cash Growth | -15.15% | 9.86% | -71.75% | 130.59% | 172.07% | Upgrade
|
Accounts Receivable | 27,466 | 21,535 | 21,415 | 23,286 | 53,300 | Upgrade
|
Other Receivables | 1,207 | 1,238 | 10,819 | 432.72 | 1,143 | Upgrade
|
Receivables | 36,673 | 30,773 | 32,234 | 23,719 | 54,443 | Upgrade
|
Inventory | 48,962 | 37,751 | 55,919 | 54,575 | 94,621 | Upgrade
|
Prepaid Expenses | 2,076 | 220.82 | 957.04 | 284.73 | 599.99 | Upgrade
|
Other Current Assets | 51,865 | 51,026 | 51,458 | 545.85 | 958.51 | Upgrade
|
Total Current Assets | 156,733 | 139,993 | 158,976 | 144,283 | 178,879 | Upgrade
|
Property, Plant & Equipment | 42,555 | 46,329 | 55,742 | 60,718 | 87,627 | Upgrade
|
Long-Term Investments | - | - | - | - | 5 | Upgrade
|
Other Intangible Assets | 68.6 | 229.47 | 491.92 | 740.21 | 4,260 | Upgrade
|
Other Long-Term Assets | 7,800 | 8,221 | 13,164 | 10,180 | 10,933 | Upgrade
|
Total Assets | 207,157 | 194,773 | 228,374 | 215,921 | 281,704 | Upgrade
|
Accounts Payable | 31,545 | 23,549 | 31,801 | 13,964 | 59,830 | Upgrade
|
Accrued Expenses | 16,705 | 8,887 | 7,216 | 3,345 | 10,864 | Upgrade
|
Short-Term Debt | 55,026 | 65,368 | 70,298 | 29,960 | 90,679 | Upgrade
|
Current Portion of Long-Term Debt | - | 591.64 | - | - | - | Upgrade
|
Current Income Taxes Payable | 172.69 | 157.19 | 1,063 | 7,209 | 5,959 | Upgrade
|
Current Unearned Revenue | 134.18 | - | 60 | 72 | 720 | Upgrade
|
Other Current Liabilities | 2,520 | 2,134 | 3,138 | 3,933 | 2,863 | Upgrade
|
Total Current Liabilities | 106,103 | 100,687 | 113,574 | 58,483 | 170,915 | Upgrade
|
Long-Term Debt | - | - | 591.64 | 2,339 | 9,980 | Upgrade
|
Other Long-Term Liabilities | 1,770 | 1,720 | 1,720 | 1,720 | 5,519 | Upgrade
|
Total Liabilities | 107,873 | 102,407 | 115,886 | 62,541 | 186,415 | Upgrade
|
Common Stock | 127,032 | 127,032 | 127,032 | 127,032 | 78,300 | Upgrade
|
Retained Earnings | -27,747 | -34,666 | -14,543 | 26,348 | 16,086 | Upgrade
|
Treasury Stock | -0.32 | -0.32 | -0.32 | -0.32 | -0.32 | Upgrade
|
Comprehensive Income & Other | - | - | - | - | 904.23 | Upgrade
|
Shareholders' Equity | 99,284 | 92,366 | 112,489 | 153,380 | 95,289 | Upgrade
|
Total Liabilities & Equity | 207,157 | 194,773 | 228,374 | 215,921 | 281,704 | Upgrade
|
Total Debt | 55,026 | 65,960 | 70,889 | 32,299 | 100,660 | Upgrade
|
Net Cash (Debt) | -37,869 | -45,738 | -52,482 | 32,860 | -72,402 | Upgrade
|
Net Cash Per Share | -2981.05 | -3600.54 | -4132.07 | 2586.61 | -9245.07 | Upgrade
|
Filing Date Shares Outstanding | 12.7 | 12.7 | 12.7 | 12.7 | 7.83 | Upgrade
|
Total Common Shares Outstanding | 12.7 | 12.7 | 12.7 | 12.7 | 7.83 | Upgrade
|
Working Capital | 50,630 | 39,305 | 45,402 | 85,800 | 7,964 | Upgrade
|
Book Value Per Share | 7815.75 | 7271.08 | 8855.18 | 12073.06 | 12167.08 | Upgrade
|
Tangible Book Value | 99,216 | 92,136 | 111,997 | 152,640 | 91,029 | Upgrade
|
Tangible Book Value Per Share | 7810.35 | 7253.02 | 8816.45 | 12014.79 | 11623.13 | Upgrade
|
Buildings | 62,604 | 62,903 | - | - | - | Upgrade
|
Machinery | 61,717 | 62,170 | - | - | - | Upgrade
|
Construction In Progress | 2,851 | - | 690.2 | - | -3,102 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.